Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma

被引：0
|
作者：
Yoshiaki Murakami
Kenichiro Uemura
Takeshi Sudo
Yasuo Hayashidani
Yasushi Hashimoto
Hiroaki Nakamura
Akira Nakashima
Taijiro Sueda
机构：
[1] Hiroshima University,Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences
来源：
Journal of Gastrointestinal Surgery | 2009年 / 13卷
关键词：
Hilar cholangiocarcinoma; Prognostic factor; Postoperative adjuvant chemotherapy; Gemcitabine; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1470 / 1479
页数：9
相关论文
共 50 条
  • [1] Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hayashidani, Yasuo
    Hashimoto, Yasushi
    Nakamura, Hiroaki
    Nakashima, Akira
    Sueda, Taijiro
    JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (08) : 1470 - 1479
  • [2] Colonization of bile with gammaproteobacteria reduces survival after surgery for pancreatic cancer in patients receiving gemcitabine-based adjuvant chemotherapy
    Terry, Charlotte
    Halle-Smith, James
    Sutcliffe, Robert
    Marudanayagam, Ravi
    Chatzizacharias, Nikolaos
    Dasari, Bobby
    Bartlett, David
    Raza, Syed
    Roberts, Keith
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [3] Excellent Pathological Response with Gemcitabine-based Protocol in Patient with Hilar Cholangiocarcinoma
    Saharia, A.
    McMillan, R.
    Kodali, S.
    Javley, M.
    Mobley, C. M.
    Hobeika, J.
    Shetty, A.
    Victor, D. W.
    McFadden, R.
    Abdelrahim, M.
    Heyne, K.
    Gaber, A. O.
    Ghobrial, R. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 769 - 770
  • [4] Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy
    Kinzler, Maximilian N.
    Klasen, Christina
    Schulze, Falko
    Herrmann, Eva
    Schnitzbauer, Andreas A.
    Trojan, Joerg
    Zeuzem, Stefan
    Wild, Peter J.
    Walter, Dirk
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [5] Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy
    Bahra, Marcus
    Pratschke, Johann
    Klein, Fritz
    Neuhaus, Peter
    Boas-Knoop, Sabine
    Puhl, Gero
    Denecke, Timm
    Pullankavumkal, Joyce R.
    Sinn, Marianne
    Riess, Hanno
    Pelzer, Uwe
    PANCREAS, 2015, 44 (06) : 930 - 936
  • [6] Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Advanced Cholangiocarcinoma Patients Treated With Gemcitabine-Based Adjuvant Chemotherapy After Surgical Resection
    Kobayashi, Hironori
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Kondo, Naru
    Sueda, Taijiro
    ANNALS OF SURGERY, 2012, 256 (02) : 288 - 296
  • [7] Prognostic Impact of Human Equilibrative Nucleoside Transporter 1 Expression in Adjuvant Gemcitabine-Based Chemotherapy After Surgical Resection for Cholangiocarcinoma
    Kobayashi, Hironori
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Kondo, Naru
    Ohge, Hiroki
    Sueda, Taijiro
    GASTROENTEROLOGY, 2012, 142 (05) : S1104 - S1104
  • [8] Aggressive surgery for hilar cholangiocarcinoma: Is it worthwhile?
    Lodge, JPA
    Ammori, BJ
    GUT, 1999, 44 : A49 - A49
  • [9] Gemcitabine-based Adjuvant Chemotherapy for Patients with Advanced Gallbladder Cancer
    Nakamura, Masafumi
    Nakashima, Hiroshi
    Abe, Toshiya
    Ensako, Takaaki
    Yoshida, Koji
    Hino, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (06) : 3125 - 3129
  • [10] High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
    Fujita, Hayato
    Ohuchida, Kenoki
    Mizumoto, Kazuhiro
    Itaba, Soichi
    Ito, Tetsuhide
    Nakata, Kohei
    Yu, Jun
    Kayashima, Tadashi
    Hayashi, Akifumi
    Souzaki, Ryota
    Tajiri, Tatsuro
    Onimaru, Manabu
    Manabe, Tatsuya
    Ohtsuka, Takao
    Tanaka, Masao
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (03) : 629 - 641
12345